Vitamin k1 and Its Relation to Vascular Calcification in Hemodialysis Patients

PHASE4CompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

January 1, 2018

Primary Completion Date

July 30, 2019

Study Completion Date

January 1, 2020

Conditions
Vascular Calcification
Interventions
DRUG

oral vitamin k1 (phylloquinone)

The enrolled patients received 5 mg of oral vitamin K1 (phylloquinone) three times /week for 6 months at the end of HD session to ensure compliance. We measured the serum dephosphorylated- uncarboxylated matrix Gla protein (dp-ucMGP) before and 6 months after vitamin K1 supplementation. In addition, plain lateral abdominal x-ray was conducted prior to and after 6 months of vitamin K supplementation to assess lumbar aorta calcification. The extent of aortic calcification score (AAC) was assessed by a semi-quantitative grading system developed by Kauppila.

Trial Locations (1)

71515

Assiut University Hospital, Asyut

All Listed Sponsors
lead

Assiut University

OTHER

NCT05060809 - Vitamin k1 and Its Relation to Vascular Calcification in Hemodialysis Patients | Biotech Hunter | Biotech Hunter